FOSAMAX PLUS D (ALENDRONATE SODIUM AND CHOLECALCIFEROL)
FOSAMAX PLUS D (ALENDRONATE SODIUM AND CHOLECALCIFEROL) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: FOSAMAX PLUS D; Generic name: ALENDRONATE SODIUM AND CHOLECALCIFEROL; Drug class: Vitamin D [EPC].
| Brand name | FOSAMAX PLUS D |
|---|---|
| Generic name | ALENDRONATE SODIUM AND CHOLECALCIFEROL |
| Drug class | Vitamin D [EPC] |
| Manufacturer | Organon LLC |
| Used for | 1 INDICATIONS AND USAGE FOSAMAX PLUS D is a combination of a bisphosphonate and vitamin D indicated for: Treatment of osteoporosis in postmenopausal women ( 1.1 ) Treatment to increase bone mass in men with osteoporosis ( 1.2 ) Limitations of use : FOSAMAX PLUS D alone should not be used to treat vitamin D deficiency. ( 1.3 ) Optimal duration of use has not been determined. For patients at low-risk for fracture, consider drug discontinuation after 3 to 5 years of use. ( 1.3 ) 1.1 Treatment of Osteoporosis in Postmenopausal Women FOSAMAX ® PLUS D is indicated for the treatment of osteoporosis in postmenopausal women. In postmenopausal women, FOSAMAX PLUS D increases bone mass and reduces the |
| Dosage | 2 DOSAGE AND ADMINISTRATION 70 mg alendronate/2800 international units vitamin D 3 or 70 mg alendronate/5600 international units vitamin D 3 tablet once weekly. ( 2.1 , 2.2 ) Instruct patients to: ( 2.3 ) Swallow tablets whole with 6-8 ounces plain water at least 30 minutes before the first food, drink, or medication of the day. Not lie down for at least 30 minutes after taking FOSAMAX PLUS D and until after food. 2.1 Treatment of Osteoporosis in Postmenopausal Women The recommended dosage is on |
| Active ingredient(s) | ALENDRONATE SODIUM |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=10307e7e-9a84-4aa1-8c5c-4b209cffe4d1 |